Recent patents in allergy and immunology: The interleukin-2 receptor
pathway agonist rezpegaldesleukin (REZPEG) for the rescue of regulatory
T cells in chronic inflammatory and autoimmune diseases
- Jonathan Zalevsky,
- Christie Fanton
Jonathan Zalevsky
Nektar Therapeutics
Corresponding Author:jzalevsky@nektar.com
Author Profile17 Apr 2024Submitted to Allergy 17 Apr 2024Submission Checks Completed
17 Apr 2024Assigned to Editor
17 Apr 2024Review(s) Completed, Editorial Evaluation Pending
11 Jul 20241st Revision Received
13 Jul 2024Assigned to Editor
13 Jul 2024Submission Checks Completed
13 Jul 2024Review(s) Completed, Editorial Evaluation Pending
24 Jul 2024Reviewer(s) Assigned
03 Aug 2024Editorial Decision: Accept
